ONCOPURE
LIVE

Serial Number

99112549

Owner

Revvity Discovery Limited

Attorney

Kevin Oliver

Filing Date

Mar 31, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ONCOPURE Trademark

Serial Number: 99112549

ONCOPURE is a trademark filed by Revvity Discovery Limited on March 31, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Revvity Discovery Limited

8100 Cambridge Research Park, Waterbeach
Cambridge CB25 9TL , GB

Entity Type: 99

Trademark Details

Filing Date

March 31, 2025

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Chemicals for use in the research of anti-cancer drugs; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, namely, for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing

Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids

cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 5, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 5, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 5, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2025 NWOS
NEW APPLICATION ENTERED
Mar 31, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Mar 31, 2025 MAFR